Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Issues related to tariffs and healthcare supply chain
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR), White House Office
Source: Senate LDA
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Preparing for All Hazards and Pathogens Reauthorization Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity, domestic manufacturing, Protecting America's Seniors' Access to Care Act (S. 3410/H.R. 7513), Reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2333/H.R. 4421)
FAST PASS Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Facilitate Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act (H.R. 6140)
Protecting American Seniors’ Access to Care Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity, domestic manufacturing, Protecting America's Seniors' Access to Care Act (S. 3410/H.R. 7513), Reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2333/H.R. 4421)
Pandemic and All-Hazards Preparedness and Response Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity, domestic manufacturing, Protecting America's Seniors' Access to Care Act (S. 3410/H.R. 7513), Reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2333/H.R. 4421)
Protecting Rural Seniors’ Access to Care Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity, domestic manufacturing, Protecting America's Seniors' Access to Care Act (S. 3410/H.R. 7513), Reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2333/H.R. 4421)
Expanding Veterans’ Options for Long Term Care Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing, minimum staffing requirements for skilled nursing facilities, S. 1749/H.R. 3227 - the Ensuring Seniors' Access to Quality Care Act regarding certified nursing assistant training, H.R. 468 - Building Americas Health Care Workforce Act regarding emergency waivers, S. 495/H.R. 1815 - Expanding Veterans Options for Long Term Care Act regarding a long-term care pilot program, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Ensuring Seniors’ Access to Quality Care Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing, minimum staffing requirements for skilled nursing facilities, S. 1749/H.R. 3227 - the Ensuring Seniors' Access to Quality Care Act regarding certified nursing assistant training, H.R. 468 - Building Americas Health Care Workforce Act regarding emergency waivers, S. 495/H.R. 1815 - Expanding Veterans Options for Long Term Care Act regarding a long-term care pilot program, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Building America’s Health Care Workforce Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing, minimum staffing requirements for skilled nursing facilities, S. 1749/H.R. 3227 - the Ensuring Seniors' Access to Quality Care Act regarding certified nursing assistant training, H.R. 468 - Building Americas Health Care Workforce Act regarding emergency waivers, S. 495/H.R. 1815 - Expanding Veterans Options for Long Term Care Act regarding a long-term care pilot program, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Ensuring Seniors’ Access to Quality Care Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing, minimum staffing requirements for skilled nursing facilities, S. 1749/H.R. 3227 - the Ensuring Seniors' Access to Quality Care Act regarding certified nursing assistant training, H.R. 468 - Building Americas Health Care Workforce Act regarding emergency waivers, S. 495/H.R. 1815 - Expanding Veterans Options for Long Term Care Act regarding a long-term care pilot program, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Expanding Veterans’ Options for Long Term Care Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing, minimum staffing requirements for skilled nursing facilities, S. 1749/H.R. 3227 - the Ensuring Seniors' Access to Quality Care Act regarding certified nursing assistant training, H.R. 468 - Building Americas Health Care Workforce Act regarding emergency waivers, S. 495/H.R. 1815 - Expanding Veterans Options for Long Term Care Act regarding a long-term care pilot program, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Medical Supplies for Pandemics Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
Strengthening America's Strategic National Stockpile Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
MADE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
H.R.3927 - MADE in America Act regarding strategies to encourage domestic medical product manufacturing
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs
Medical Supplies for Pandemics Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
Strengthening America’s Strategic National Stockpile Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
PREVENT Pandemics Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
CLEAN Future Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
CLEAN Future Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Medical device sterilization, H.R.1512 - CLEAN Future Act regarding monitoring
CLEAN Future Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
CLEAN Future Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
CLEAN Future Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Medical device sterilization, H.R.1512 - CLEAN Future Act regarding monitoring
CLEAN Future Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
SUPPLIES Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
SUPPLIES Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production
SUPPLIES Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production
SUPPLIES Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
SUPPLIES Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
SUPPLIES Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S.1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S.1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
United States Innovation and Competition Act of 2021
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Healthcare supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
PPE in America Act
Client: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP · Firm: MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Issues related to tariffs and healthcare supply chain
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Healthcare supply chain and resiliency, issues related to medical device reprocessing, issues related to federal Medicare/Medicaid reimbursement for medical products
Issues related to tariffs and healthcare supply chain
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE
Healthcare supply chain and resiliency, issues related to medical provider reimbursement and federal funding for Medicaid and Medicare.
Issues related to tariffs and healthcare supply chain, reauthorization of the African Growth and Opportunity Act
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), SENATE, Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Issues related to the VA Medical/Surgical Prime Vendor Program
Healthcare supply chain and resiliency, medical device reprocessing, issues related to medical provider reimbursement and federal funding for Medicaid and Medicare.
Issues related to tariffs and healthcare supply chain, issues related to onshoring medical device production, reauthorization of the African Growth and Opportunity Act
Filing targets: Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Issues related to tariffs and healthcare supply chain
Healthcare supply chain and resiliency, medical device reprocessing, issues related to medical provider reimbursement and federal funding for Medicaid and Medicare.
Tariffs and healthcare supply chain, onshoring medical device production
Tariffs and healthcare supply chain
Healthcare supply chain and resiliency, medical device reprocessing
Tariffs and healthcare supply chain, onshoring medical device production
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR)
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2024 · fourth_quarter · Q4
Trade-related healthcare supply chain and resiliency issues
Issues regarding medical device sterilization.
Healthcare supply chain and resiliency, domestic manufacturing, product continuity and availability
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2024 · third_quarter · Q3
Trade-related healthcare supply chain and resiliency issues
Issues regarding medical device sterilization.
Healthcare supply chain and resiliency, domestic manufacturing, product continuity and availability
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2024 · second_quarter · Q2
Section 301 tariffs and exclusions
Healthcare supply chain, resiliency, product continuity, domestic manufacturing, Protecting America's Seniors' Access to Care Act (S. 3410/H.R. 7513), Reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2333/H.R. 4421)
Trade-related healthcare supply chain and resiliency issues
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2024 · first_quarter · Q1
Healthcare supply chain, resiliency, product continuity, and domestic manufacturing.
Section 301 tariffs and exclusions
Issues regarding medical device sterilization.
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2023 · fourth_quarter · Q4
Trade-related healthcare supply chain and resiliency issues
Issues regarding medical device sterilization
Healthcare supply chain, resiliency, product continuity, and domestic manufacturing.
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2023 · third_quarter · Q3
Healthcare supply chain, resiliency, product continuity, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Trade-related healthcare supply chain and resiliency issues
Issues regarding medical device sterilization
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2023 · second_quarter · Q2
Issues regarding medical device sterilization
Section 301 tariffs and exclusions
Healthcare supply chain and resiliency
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2023 · first_quarter · Q1
Issues regarding medical device sterilization
Healthcare supply chain and resiliency
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing.
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2022 · fourth_quarter · Q4
Section 301 tariffs and exclusions
Healthcare supply chain and resiliency
Issues regarding medical device sterilization
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2022 · third_quarter · Q3
Section 301 tariffs
Healthcare supply chain, resiliency and product continuity
Issues regarding medical device sterilization
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2022 · second_quarter · Q2
Healthcare supply chain and resiliency
Issues regarding medical device sterilization
Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2022 · first_quarter · Q1
Medical device sterilization
Healthcare supply chain and resiliency
Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2021 · fourth_quarter · Q4
Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs
Medical device sterilization
Healthcare supply chain and resiliency
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2021 · third_quarter · Q3
Section 301 tariffs
Healthcare supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile
Medical device sterilization
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2021 · third_quarter · RA
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2021 · second_quarter · Q2
Health care supply chain and resiliency
Medical device sterilization, H.R.1512 - CLEAN Future Act regarding monitoring
Section 301 tariffs, S.1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs
MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP via MEDLINE, FORMERLY REPORTED AS MEDLINE INDUSTRIES, LP
2021 · second_quarter · Q2
Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production
Health care supply chain and resiliency
Section 301 tariffs, S.1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs
Issues related to the VA Medical/Surgical Prime Vendor Program
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Section 301 tariffs and exclusions
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Section 301 tariffs and exclusions
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Facilitate Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act (H.R. 6140)
Issues regarding medical device sterilization.
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, U.S. Trade Representative (USTR), White House Office
Trade-related healthcare supply chain and resiliency issues
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE
Section 301 tariffs and exclusions
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
Section 301 tariffs and exclusions
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
Healthcare supply chain, resiliency, product continuity and issues surrounding medical device reprocessing, minimum staffing requirements for skilled nursing facilities, S. 1749/H.R. 3227 - the Ensuring Seniors' Access to Quality Care Act regarding certified nursing assistant training, H.R. 468 - Building Americas Health Care Workforce Act regarding emergency waivers, S. 495/H.R. 1815 - Expanding Veterans Options for Long Term Care Act regarding a long-term care pilot program, reauthorization of the Pandemic and All-Hazards Preparedness and Response Act concerning domestic manufacturing
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Section 301 tariffs and exclusions
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), U.S. Trade Representative (USTR)
Healthcare supply chain, resiliency and product continuity
H.R.3927 - MADE in America Act regarding strategies to encourage domestic medical product manufacturing
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Healthcare supply chain and resiliency
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Healthcare supply chain, resiliency and product continuity
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Healthcare supply chain and resiliency
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Healthcare supply chain and resiliency
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), White House Office
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
Section 301 tariffs, S. 1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs, medical device sterilization, H.R. 1512 - CLEAN Future Act regarding monitoring, Health care supply chain and resiliency, S. 308 - PPE in America Act regarding strategic national stockpile, H.R. 346 - SUPPLIES Act regarding domestic medical supply production,
Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
Medical device sterilization, H.R.1512 - CLEAN Future Act regarding monitoring
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)